{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T11:51:14Z","timestamp":1784807474036,"version":"3.55.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T00:00:00Z","timestamp":1768521600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","heartrhythmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart Rhythm"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.hrthm.2026.01.016","type":"journal-article","created":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T15:59:40Z","timestamp":1768838380000},"page":"1212-1220","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["A review of etripamil: A new paradigm for treating paroxysmal supraventricular tachycardia for an informed, shared decision"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3461-505X","authenticated-orcid":false,"given":"James E.","family":"Ip","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hrthm.2026.01.016_bib1","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1111\/jce.15109","article-title":"Prevalence and incidence of patients with paroxysmal supraventricular tachycardia in the United States","volume":"32","author":"Rehorn","year":"2021","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hrthm.2026.01.016_bib2","doi-asserted-by":"crossref","first-page":"S169","DOI":"10.1016\/j.annemergmed.2025.06.409","article-title":"391 Emergency department visits for PSVT: an analysis of the HCUP Nationwide Emergency Department sample","volume":"86","author":"Desai","year":"2025","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.hrthm.2026.01.016_bib3","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1001\/jama.2018.20437","article-title":"Wearable devices for cardiac rhythm diagnosis and management","volume":"321","author":"Ip","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.hrthm.2026.01.016_bib4","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1001\/jama.2019.1681","article-title":"Evaluation of cardiac rhythm abnormalities from wearable devices","volume":"321","author":"Ip","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.hrthm.2026.01.016_bib5","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0196-0644(98)70277-X","article-title":"Comparison of treatment of supraventricular tachycardia by Valsalva maneuver and carotid sinus massage","volume":"31","author":"Lim","year":"1998","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.hrthm.2026.01.016_bib6","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1016\/S0140-6736(15)61485-4","article-title":"Postural modification to the standard Valsalva manoeuvre for emergency treatment of supraventricular tachycardias (REVERT): a randomised controlled trial","volume":"386","author":"Appelboam","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.hrthm.2026.01.016_bib7","first-page":"e506","article-title":"2015 ACC\/AHA\/HRS guideline for the management of adult patients with supraventricular tachycardia: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice guidelines and the Heart Rhythm Society","volume":"133","author":"Page","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2026.01.016_bib8","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1161\/01.CIR.0000091380.04100.84","volume":"108","author":"Blomstr\u00f6m-Lundqvist","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2026.01.016_bib9","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1161\/01.CIR.71.1.104","article-title":"Termination of paroxysmal supraventricular tachycardia with a single oral dose of diltiazem and propranolol","volume":"71","author":"Yeh","year":"1985","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2026.01.016_bib10","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/S0735-1097(00)01128-1","article-title":"Efficacy and safety of out-of-hospital self-administered single-dose oral drug treatment in the management of infrequent, well-tolerated paroxysmal supraventricular tachycardia","volume":"37","author":"Alboni","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2026.01.016_bib11","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1093\/eurheartj\/ehz467","article-title":"2019 ESC Guidelines for the management of patients with supraventricular tachycardia The Task Force for the management of patients with supraventricular tachycardia of the European Society of Cardiology (ESC)","volume":"41","author":"Brugada","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2026.01.016_bib12","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/cpdd.1383","article-title":"Pharmacokinetics and pharmacodynamics of etripamil, an intranasally administered, fast-acting, nondihydropyridine calcium channel blocker","volume":"13","author":"Ip","year":"2024","journal-title":"Clin Pharmacol Drug Dev"},{"key":"10.1016\/j.hrthm.2026.01.016_bib13","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.jacc.2018.04.082","article-title":"Etripamil nasal spray for rapid conversion of supraventricular tachycardia to sinus rhythm","volume":"72","author":"Stambler","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2026.01.016_bib14","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.122.010915","article-title":"First randomized, multicenter, placebo-controlled study of self-administered intranasal etripamil for acute conversion of spontaneous paroxysmal supraventricular tachycardia (NODE-301)","volume":"15","author":"Stambler","year":"2022","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hrthm.2026.01.016_bib15","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/S0140-6736(23)00776-6","article-title":"Self-administered intranasal etripamil using a symptom-prompted, repeat-dose regimen for atrioventricular-nodal-dependent supraventricular tachycardia (RAPID): a multicentre, randomised trial","volume":"402","author":"Stambler","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.hrthm.2026.01.016_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.hrthm.2024.03.309","article-title":"CE-482905-001 Self-administered etripamil nasal spray rapidly terminated spontaneous paroxysmal supraventricular tachycardia (PSVT): analysis of open-label treatment in the RAPID study","volume":"21","author":"Stambler","year":"2024","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2026.01.016_bib17","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.028227","article-title":"Etripamil nasal spray for conversion of repeated spontaneous episodes of paroxysmal supraventricular tachycardia during long-term follow-up: results from the NODE-302 study","volume":"12","author":"Ip","year":"2023","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.hrthm.2026.01.016_bib18","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1016\/j.jacc.2024.03.384","article-title":"Etripamil nasal spray for recurrent paroxysmal supraventricular tachycardia conversion","volume":"83","author":"Ip","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2026.01.016_bib19","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1111\/jce.70086","article-title":"Etripamil nasal spray for recurrent paroxysmal supraventricular tachycardia conversion: results from the NODE-303 open-label study","volume":"36","author":"Ip","year":"2025","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hrthm.2026.01.016_bib20","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.123.011681","article-title":"Self-administered etripamil nasal spray relieved symptoms, decreased heart rate, and reduced medical interventions during atrioventricular nodal-dependent paroxysmal supraventricular tachycardia","volume":"17","author":"Stambler","year":"2024","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hrthm.2026.01.016_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.hrthm.2023.03.424","article-title":"Effect of etripamil nasal spray on ventricular rate in patients experiencing symptomatic atrial fibrillation","volume":"20","author":"Dorian","year":"2023","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2026.01.016_bib22","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1161\/CIRCEP.123.012567","article-title":"Multicenter, phase 2, randomized controlled study of the efficacy and safety of etripamil nasal spray for the acute reduction of rapid ventricular rate in patients with symptomatic atrial fibrillation (ReVeRA-201)","volume":"16","author":"Camm","year":"2023","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hrthm.2026.01.016_bib23","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1001\/jamacardio.2025.0417","article-title":"Self-administered etripamil and emergency department visits in supraventricular tachycardia: a secondary analysis of a randomized clinical trial","volume":"10","author":"Pokorney","year":"2025","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.hrthm.2026.01.016_bib24","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1111\/jce.15680","article-title":"Late pacemaker implantation after atrioventricular nodal reentrant tachycardia ablation: a systematic review and meta-analysis","volume":"33","author":"Sim","year":"2022","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hrthm.2026.01.016_bib25","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1111\/jce.15677","article-title":"Atrioventricular nodal re-entrant tachycardia: are there unknown long-term consequences of ablating the (incompletely) known?","volume":"33","author":"Ip","year":"2022","journal-title":"J Cardiovasc Electrophysiol"}],"container-title":["Heart Rhythm"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527126000342?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527126000342?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T20:02:37Z","timestamp":1779912157000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1547527126000342"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S1547527126000342"],"URL":"https:\/\/doi.org\/10.1016\/j.hrthm.2026.01.016","relation":{},"ISSN":["1547-5271"],"issn-type":[{"value":"1547-5271","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A review of etripamil: A new paradigm for treating paroxysmal supraventricular tachycardia for an informed, shared decision","name":"articletitle","label":"Article Title"},{"value":"Heart Rhythm","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hrthm.2026.01.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Heart Rhythm Society.","name":"copyright","label":"Copyright"}]}}